Clinical Trial Update: Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea [NA]

View source ↗

Summary

Clinical trial update describing TOXCLEAN as an add-on to standard of care for Clostridium difficile-associated diarrhea, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile-associated Diarrhea

Drugs mentioned

• TOXCLEAN

Snippet

Sponsor: ABResearch S.r.l. | Conditions: Clostridium; Difficile, As Cause of Disease Classified Elsewhere, Clostridium Difficile Diarrhea | NA | Status: RECRUITING